Company Filing History:
Years Active: 2010
Title: Djelila Mezaache: Innovator in Quick Dissolve Oral Dosage Forms
Introduction
Djelila Mezaache, based in Aldie, VA, is a notable inventor known for his contributions to the pharmaceutical industry. With a focus on improving oral dosage forms, he has developed innovative solutions that enhance patient convenience and compliance.
Latest Patents
Djelila holds a patent for "Quick dissolve compositions and tablets based thereon." This invention presents a composition that enables oral dosage forms to dissolve in the mouth in less than 40 seconds, eliminating the need for conventional super disintegrants. The patent specifies that the composition includes liquiflash particles and an excipient mass, which contributes to improved hardness and friability of the dosage forms. Its formulation allows the active ingredient to remain effectively enclosed within microspheres even when the composition is compressed, facilitating the production of robust tablets.
Career Highlights
Djelila is currently affiliated with Biovail Laboratories International S.r.l., where he contributes to innovative pharmaceutical developments. His work at the company showcases his commitment to enhancing medication delivery systems through practical and scientific advancements in formulations.
Collaborations
Throughout his career, Djelila has collaborated with professionals such as Naima Mezaache and Steven E Frisbee. These partnerships highlight the importance of teamwork in driving advancements in pharmaceutical technologies and improving patient care solutions.
Conclusion
Djelila Mezaache's inventive spirit and dedication to creating efficient pharmaceutical compositions make him a significant figure in the field of oral dosage innovations. His patented work continues to influence the industry, promising better solutions for patients worldwide.